Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.

[1]  P. Apostolopoulos,et al.  Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study , 2016, Scandinavian journal of gastroenterology.

[2]  M. Bair,et al.  Systematic review with meta‐analysis: 10‐ or 14‐day sequential therapy vs. 14‐day triple therapy in the first line treatment of Helicobacter pylori infection , 2016, Alimentary pharmacology & therapeutics.

[3]  Jason Y. Park,et al.  Review article: the global emergence of Helicobacter pylori antibiotic resistance , 2015, Alimentary pharmacology & therapeutics.

[4]  J. Kim,et al.  Sequential or concomitant therapy for eradication of Helicobacter pylori infection: A systematic review and meta‐analysis , 2015, Journal of gastroenterology and hepatology.

[5]  V. Papastergiou,et al.  Treatment of Helicobacter Pylori infection: optimization strategies in a high resistance era , 2015, Expert opinion on pharmacotherapy.

[6]  D. Ye,et al.  Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis , 2015, BMJ : British Medical Journal.

[7]  Mingjun Song,et al.  Ten‐day triple therapy versus sequential therapy versus concomitant therapy as first‐line treatment for Helicobacter pylori infection , 2015, Journal of gastroenterology and hepatology.

[8]  C. O'Morain,et al.  Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study , 2015, Alimentary pharmacology & therapeutics.

[9]  Deng-Chyang Wu,et al.  Reverse Sequential Therapy Achieves a Similar Eradication Rate as Standard Sequential Therapy for Helicobacter pylori Eradication: A Randomized Controlled Trial , 2015, Helicobacter.

[10]  Byung-Wook Kim,et al.  Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies. , 2015, World journal of gastroenterology.

[11]  T. Deng,et al.  Meta-analysis of sequential, concomitant and hybrid therapy for Helicobacter pylori eradication. , 2015, Internal medicine.

[12]  S. Y. Kim,et al.  [Ten day concomitant therapy is superior to ten day sequential therapy for Helicobacter pylori eradication]. , 2014, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[13]  Deng-Chyang Wu,et al.  Randomized Controlled Trial Comparing 7-Day Triple, 10-Day Sequential, and 7-Day Concomitant Therapies for Helicobacter pylori Infection , 2014, Antimicrobial Agents and Chemotherapy.

[14]  J. Y. Lee,et al.  A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea , 2014, Scandinavian journal of gastroenterology.

[15]  S. Georgopoulos.  “Concomitant” or “sequential” eradication of Helicobacter pylori: which regimen comes first? , 2014, Annals of gastroenterology.

[16]  C. Hassan,et al.  Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study. , 2014, Journal of medical microbiology.

[17]  Minhu Chen,et al.  A Comparative Study of Sequential Therapy and Standard Triple Therapy for Helicobacter pylori Infection: A Randomized Multicenter Trial , 2014, The American Journal of Gastroenterology.

[18]  D. Graham,et al.  Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[19]  D. Sgouras,et al.  Clinical Evaluation of a Ten‐Day Regimen with Esomeprazole, Metronidazole, Amoxicillin, and Clarithromycin for the Eradication of Helicobacter pylori in a High Clarithromycin Resistance Area , 2013, Helicobacter.

[20]  A. Mentis,et al.  Is there a nonbismuth quadruple therapy that can reliably overcome bacterial resistance? , 2013, Gastroenterology.

[21]  C. Hassan,et al.  Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study. , 2013, Clinics and research in hepatology and gastroenterology.

[22]  C. Scarpignato,et al.  Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy , 2013, BMJ.

[23]  J. Gisbert,et al.  Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance. , 2013, Gastroenterology.

[24]  H. Jung,et al.  Clinical Outcomes of Two‐Week Sequential and Concomitant Therapies for Helicobacter pylori Eradication: A Randomized Pilot Study , 2013, Helicobacter.

[25]  J. Gisbert,et al.  Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice , 2013, Gut.

[26]  F. Laoudi,et al.  Nonbismuth Quadruple “Concomitant” Therapy Versus Standard Triple Therapy, Both of the Duration of 10 Days, for First-Line H. Pylori Eradication: A Randomized Trial , 2013, Journal of clinical gastroenterology.

[27]  Hsiu‐Po Wang,et al.  Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial , 2013, The Lancet.

[28]  V. Papastergiou,et al.  Current options for the treatment of Helicobacter pylori , 2013, Expert opinion on pharmacotherapy.

[29]  H. Goossens,et al.  Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption , 2012, Gut.

[30]  R. Vilaichone,et al.  Pilot Studies to Identify the Optimum Duration of Concomitant Helicobacter pylori Eradication Therapy in Thailand , 2012, Helicobacter.

[31]  V. Papastergiou,et al.  Helicobacter   pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy , 2012, Gastroenterology research and practice.

[32]  Gian Franco Gensini,et al.  Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report , 2012, Gut.

[33]  Deng-Chyang Wu,et al.  Lansoprazole‐based sequential and concomitant therapy for the first‐line Helicobacter pylori eradication , 2012, Journal of digestive diseases.

[34]  J. Gisbert,et al.  Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori , 2012, Clinical and experimental gastroenterology.

[35]  E. Xirouchakis,et al.  Evaluation of a Four‐drug, Three‐antibiotic, Nonbismuth–containing “Concomitant” Therapy as First‐line Helicobacter pylori Eradication Regimen in Greece , 2012, Helicobacter.

[36]  J. Gisbert,et al.  Key Points for Designing and Reporting Helicobacter pylori Therapeutic Trials: A Personal View , 2011, Helicobacter.

[37]  J. Crowley,et al.  14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial , 2011, The Lancet.

[38]  D. Graham,et al.  Is There a Benefit to Extending the Duration of Helicobacter pylori Sequential Therapy to 14 Days? , 2011, Helicobacter.

[39]  D. Graham,et al.  Understanding and Appreciating Sequential Therapy for HelicobacterpyloriEradication , 2011, Journal of clinical gastroenterology.

[40]  C. Hassan,et al.  Worldwide H. pylori antibiotic resistance: a systematic review. , 2010, Journal of gastrointestinal and liver diseases : JGLD.

[41]  D. Graham,et al.  Helicobacter pylori treatment in the era of increasing antibiotic resistance , 2010, Gut.

[42]  K. McColl.  Helicobacter pylori Infection REPLY , 2010 .

[43]  D. Graham,et al.  Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[44]  D. Graham,et al.  A Report Card to Grade Helicobacter pylori Therapy , 2007, Helicobacter.

[45]  L. Kupčinskas,et al.  The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.